Brandinium

Trademark search for:

SIMISURE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2024-05-02 — Application filed
  • 2024-05-02 — Application filed
  • 2024-05-02 — Application filed
  • 2024-06-27 — Assigned to examiner
  • 2024-07-09 — Final disposition recorded
  • 2024-07-09 — Final disposition recorded
  • 2024-07-09 — Final disposition recorded
  • 2024-10-09 — Teas/email correspondence entered
  • 2024-10-09 — Correspondence received in law office
  • 2024-10-09 — Office action issued
  • 2024-10-11 — Previous allowance count withdrawn
  • 2024-10-11 — Approved for pub - principal register
  • 2024-10-11 — Approved for pub - principal register
  • 2024-11-13 — Notification of notice of publication e-mailed
  • 2024-11-19 — Published for opposition
  • 2024-11-19 — Official gazette publication confirmation e-mailed
  • 2024-12-17 — Extension of time to oppose received
  • 2025-01-17 — Opposition instituted no. 999999
  • 2025-01-18 — Extension of time to oppose process - terminated
  • 2025-03-03 — Opposition sustained no. 999999
  • 2025-03-03 — Application abandoned
  • 2025-03-03 — Application abandoned
  • 2025-03-03 — Opposition terminated no. 999999
  • 2025-03-03 — Final status recorded

Owner Information

FARMACIAS DE SIMILARES, S.A. DE C.V.
MEXICO CITY MX
FARMACIAS DE SIMILARES, S.A. DE C.V.
MEXICO CITY MX

Correspondent

GEOFFREY M. MCNUTT MILLEN, WHITE, ZELANO & BRANIGAN, P.C.
2200 CLARENDON BLVD., SUITE 1400
ARLINGTON, VA 22201
UNITED STATES

Filing Details

Filing Date:
2024-05-02
Status Date:
2025-03-03
Category:
Pharmaceuticals
Filing Year:
2024

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.